Study authors said the treatment 'was found to be effective and safe in reducing the viral load in patients with mild, symptomatic COVID-19 infection.'
At the latest count, there are now 62 trials, with 32 randomized controlled trials, and over 60 peer-reviewed papers documenting the success of Ivermectin.
Independent MP Derek Sloan hosted a press conference on Ottawa’s Parliament Hill to give Canadians who have been hurt by COVID-19 policies a chance to speak freely.
While there is certainly some level of tragedy happening in India, distinctions have to be drawn between the actual effects of COVID-19, and other contributing factors.
The study’s authors found large, statistically significant reductions in mortality and recovery time in addition to ‘significantly reduced risks of contracting COVID-19 with the regular use of ivermectin.’